Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chris Cassa, Ph.D.


This page shows the publications co-authored by Chris Cassa and Shamil Sunyaev.
Connection Strength

  1. Reply to 'Selective effects of heterozygous protein-truncating variants'. Nat Genet. 2019 01; 51(1):3-4.
    View in: PubMed
    Score: 0.795
  2. A literature review at genome scale: improving clinical variant assessment. Genet Med. 2018 09; 20(9):936-941.
    View in: PubMed
    Score: 0.746
  3. Estimating the selective effects of heterozygous protein-truncating variants from human exome data. Nat Genet. 2017 May; 49(5):806-810.
    View in: PubMed
    Score: 0.704
  4. Applicability of the Mutation-Selection Balance Model to Population Genetics of Heterozygous Protein-Truncating Variants in Humans. Mol Biol Evol. 2019 08 01; 36(8):1701-1710.
    View in: PubMed
    Score: 0.207
  5. novoCaller: a Bayesian network approach for de novo variant calling from pedigree and population sequence data. Bioinformatics. 2019 04 01; 35(7):1174-1180.
    View in: PubMed
    Score: 0.202
  6. An argument for early genomic sequencing in atypical cases: a WISP3 variant leads to diagnosis of progressive pseudorheumatoid arthropathy of childhood. Rheumatology (Oxford). 2016 Mar; 55(3):586-9.
    View in: PubMed
    Score: 0.159
  7. Dominance of Deleterious Alleles Controls the Response to a Population Bottleneck. PLoS Genet. 2015 Aug; 11(8):e1005436.
    View in: PubMed
    Score: 0.158
  8. Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease. Mol Genet Genomic Med. 2015 Sep; 3(5):413-23.
    View in: PubMed
    Score: 0.154
  9. Evidence for secondary-variant genetic burden and non-random distribution across biological modules in a recessive ciliopathy. Nat Genet. 2020 11; 52(11):1145-1150.
    View in: PubMed
    Score: 0.056
  10. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Nat Genet. 2019 09; 51(9):1308-1314.
    View in: PubMed
    Score: 0.052
  11. An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery. NPJ Genom Med. 2018; 3:21.
    View in: PubMed
    Score: 0.048
  12. Identification of cis-suppression of human disease mutations by comparative genomics. Nature. 2015 Aug 13; 524(7564):225-9.
    View in: PubMed
    Score: 0.039
  13. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol. 2014 Mar 25; 15(3):R53.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.